All News

Viral/Non-Viral Vectors

Unlock the Potential of Regulatory T Cells in Cell Therapy Manufacturing 
24 September 2024
Unlock the Potential of Regulatory T Cells in Cell Therapy Manufacturing 
Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing
14 May 2024
Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing
Are you looking for a
Maximizing cost efficiency, reducing GMP footprint, and eliminating bottlenecks in Lentiviral virus production: A Case Study with the Cytegrity™ Producer Cell Line in the scale-X™ Fixed-Bed Bioreactor.
25 March 2024
Maximizing cost efficiency, reducing GMP footprint, and eliminating bottlenecks in Lentiviral virus production: A Case Study with the Cytegrity™ Producer Cell Line in the scale-X™ Fixed-Bed Bioreactor.
Discover revolutionary advancements in LVV
Employing Innovative Approaches, Technological Advancements and Collaborative Strategies to Address Industry Challenges
29 February 2024
Employing Innovative Approaches, Technological Advancements and Collaborative Strategies to Address Industry Challenges
Sharmilee Patel, Head of Business
POPULAR NEWS ITEMS
Image
11 October 2024

Cell and Gene Therapies News Round-Up: October 11

Image
4 October 2024

Cell and Gene Therapies News Round-Up: October 4

Image
24 September 2024

Unlock the Potential of Regulatory T Cells in Cell Therapy Manufacturing 

Going Non-Viral: How Cell Therapy Manufacturing is Moving Away From Viral Vectors
26 February 2024
Going Non-Viral: How Cell Therapy Manufacturing is Moving Away From Viral Vectors
Are you interested in editing
In Conversation with Jake Lesnik: An Innovative Solution to <i>ex vivo</i> Delivery Challenges
22 February 2024
In Conversation with Jake Lesnik: An Innovative Solution to ex vivo Delivery Challenges
Jake Lesnik, VP of Business
Overcoming Connectivity and Scalability Challenges with Gene Therapy Manufacturing Processes
7 February 2024
Overcoming Connectivity and Scalability Challenges with Gene Therapy Manufacturing Processes
Dan UpDyke, Strategic Marketing Manager
Optimizing Cell and Gene Therapy Development: Tackling Challenges, Learning from Vaccines, and the Power of Strategic Partnerships
31 January 2024
Optimizing Cell and Gene Therapy Development: Tackling Challenges, Learning from Vaccines, and the Power of Strategic Partnerships
Peter Abbink, Managing Director of
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

Cell and Gene Therapies News Round-Up: October 11

Image

Cell and Gene Therapies News Round-Up: October 4

Image

Unlock the Potential of Regulatory T Cells in Cell Therapy Manufacturing